Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Biocon Biologics reports positive Phase 3 results for Yesintek, biosimilar to Ustekinumab Biocon Biologics Ltd., a global leader in biosimilar medicines and a subsidiary of India’s pioneering biopharmaceutical giant Biocon… byPallavi MadhirajuMarch 8, 2025